AL
ARLZ

Airain Ltd’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Airain Ltd’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$44K Buy
+32,264
New +$46.6K ﹤0.01% 805

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return

Airain Ltd's ARLZ Position: Q2 2017 in Review

Airain Ltd opened a new position in Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2017: 32,264 shares worth $44K. The stake represents ﹤0.01% of the portfolio and ranks #805 among its holdings.

72 funds tracked by Wall St. Rank hold ARLZ as of Q2 2017.

  • Airain Ltd held 32,264 shares of Aralez Pharmaceuticals Inc. worth $44K as of Q2 2017.
  • Aralez Pharmaceuticals Inc. was a new Airain Ltd position in Q2 2017.
  • Aralez Pharmaceuticals Inc. made up ﹤0.01% of Airain Ltd's portfolio in Q2 2017, its #805 holding.
  • 72 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.